Since its initial public offering in late 2019, the German coronavirus vaccine developer BioNTech (NASDAQ: BNTX) has grown more than 2,150%, making its early investors quite rich. Let's examine three tricks that you can use to screen for millionaire-makers like BioNTech, so that you'll be ready to invest when you see one. Biotechs need to capture a significant share of a potential market to succeed.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting